Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random...

por Bonifácio, Lívia Pimenta, Ramacciotti, Eduardo, Agati, Leandro Barile, Vilar, Fernando Crivelenti, da Silva, Anna Christina Tojal, Louzada, Paulo, da Fonseca, Benedito Antônio Lopes, de Souza, Hayala Cristina Cavenague, de Oliveira, Caroline Candida Carvalho, Aguiar, Valéria Cristina Resende, Quadros, Carlos Augusto de Aguiar, Dusilek, Cesar, Itinose, Kengi, Risson, Ricardo, Ferreira, Lucas Roberto Rivabem, Lopes, Renato Delascio, Kallas, Esper Georges, Bellissimo-Rodrigues, Fernando
Publicado 2023